Those considering BPC-157 should understand they are using an experimental compound with unknown long-term effects, sourced from an unregulated market where product quality and purity cannot be guaranteed
Where should I go next after reading this GHK-Cu Topical Serum guide
A research paper published in 1997 found that epithalon treatment decreased the size of tumors in test subjects with ovarian, uterine, and cervical cancer while helping to restore cellular immunity [14]
It's currently labeled as a category 2 substance, meaning that the FDA has identified an ingredient as having a possible safety risk and it cannot be used in compounded medications
Most people experience mild side effects like redness at the injection site, headaches, flushing, or dizziness
The tumor-suppressor p53 plays a pivotal role in cellular responses to various stressors